Plant Health Care plc Stock

Equities

PHC

GB00B01JC540

Agricultural Chemicals

Delayed London S.E. 06:30:17 2024-04-23 am EDT 5-day change 1st Jan Change
3.956 GBX +2.49% Intraday chart for Plant Health Care plc +8.39% +7.22%
Sales 2023 * 12M Sales 2024 * 16.6M Capitalization 16.26M
Net income 2023 * -2M Net income 2024 * - EV / Sales 2023 * 0.96 x
Net cash position 2023 * 4.8M Net cash position 2024 * 5.1M EV / Sales 2024 * 0.67 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 44.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.49%
1 week+8.39%
Current month+10.20%
1 month+14.01%
3 months+6.07%
6 months-40.28%
Current year+7.22%
More quotes
1 week
3.60
Extreme 3.6
4.14
1 month
3.32
Extreme 3.3224
4.14
Current year
3.30
Extreme 3.3
4.18
1 year
3.20
Extreme 3.1978
11.90
3 years
3.20
Extreme 3.1978
17.60
5 years
3.20
Extreme 3.1978
19.50
10 years
3.20
Extreme 3.1978
129.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 15-05-05
Director of Finance/CFO 56 13-08-31
Chairman 70 12-07-31
Members of the board TitleAgeSince
Director/Board Member 69 19-10-31
Chairman 70 12-07-31
Director/Board Member 44 13-06-06
More insiders
Date Price Change Volume
24-04-23 3.956 +2.49% 122
24-04-22 3.86 +8.12% 88,493
24-04-19 3.57 -0.83% 350,343
24-04-18 3.6 -5.01% 39,809
24-04-17 3.79 +3.84% 632,940

Delayed Quote London S.E., April 23, 2024 at 06:30 am EDT

More quotes
Plant Health Care plc provides peptides for plant protection for global agricultural markets. The Company offers products to improve the health, vigor and yield of various field crops, such as corn, soybeans, potatoes and rice, as well as specialty crops, such as fruits and vegetables. It operates globally through subsidiaries, distributors and supply agreements with various industry partners. Its biological products help growers to protect their crops from stress and diseases, and to produce fruit and vegetables. Its segments include Americas, Mexico and Rest of World. The Americas segment includes activities in both North and South America. The Mexico segment includes sales of Harpinab and third-party products. Harpinab is sold as H2Copla into sugar cane in Brazil, through Coplacana, which is a distributor of inputs for this crop. The Rest of World segment includes operations of the United Kingdom and Spanish subsidiaries, which together operate across Europe and South Africa.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise